Genfit S.A. (GNFT)
NASDAQ: GNFT · Real-Time Price · USD
3.670
+0.120 (3.38%)
At close: Mar 28, 2025, 4:00 PM
3.595
-0.075 (-2.04%)
After-hours: Mar 28, 2025, 4:25 PM EDT
Genfit Employees
Genfit had 159 employees as of December 31, 2023. The number of employees increased by 11 or 7.43% compared to the previous year.
Employees
159
Change (1Y)
11
Growth (1Y)
7.43%
Revenue / Employee
$542,297
Profits / Employee
$150,079
Market Cap
182.84M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
GNFT News
- 10 days ago - GENFIT Announces Completion of Non-dilutive Royalty Financing Agreement with HCRx and Results of Repurchase Offer to 2025 OCEANEs holders - GlobeNewsWire
- 20 days ago - Royalty Financing with HCRx: GENFIT Announces Approval of the Amendment of the Terms and Conditions of its 2025 OCEANEs - GlobeNewsWire
- 4 weeks ago - GENFIT Announces Revenues and Cash Position as of December 31, 2024 - GlobeNewsWire
- 5 weeks ago - GENFIT Announces the Preliminary Results of the Repurchase Offer to 2025 OCEANEs holders and the Convening of the 2025 OCEANEs holders' general meeting - GlobeNewsWire
- 6 weeks ago - GENFIT Announces the Amendment of the Final Terms of the Dual Proposal to the 2025 OCEANEs Holders - GlobeNewsWire
- 7 weeks ago - GENFIT Outlines Anticipated New Clinical Trial Initiations, Development Milestones and Data Readouts in 2025 - GlobeNewsWire
- 2 months ago - GENFIT Announces Non-Dilutive Royalty Financing Agreement and Debt Overhang Resolution Plan - GlobeNewsWire
- 2 months ago - GENFIT Announces 2025 Financial Calendar - GlobeNewsWire